Longevity Health Holdings Inc. (XAGEW)
XAGEW Stock Price Chart
Explore Longevity Health Holdings Inc. interactive price chart. Choose custom timeframes to analyze XAGEW price movements and trends.
XAGEW Company Profile
Discover essential business fundamentals and corporate details for Longevity Health Holdings Inc. (XAGEW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Mar 2025
Employees
15.00
Website
https://www.carmellcosmetics.comCEO
Rajiv Sarman Shukla
Description
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
XAGEW Financial Timeline
Browse a chronological timeline of Longevity Health Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
XAGEW Stock Performance
Access detailed XAGEW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.